Response to “Translational toxicology of sex specific PFNA clearance in rat and human”

Davies B, Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res 10(7):1093–1095. https://doi.org/10.1023/a:1018943613122 Hethey C, Mielke H, Gundert-Remy U (2019a) Comment on ‘Kim, S.-J., Choi, E.-J., Choi, G.-W., Lee, Y.-B., and Cho, H.-Y. (2019). Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model, Arch Toxicol 93:311-330’. Arch Toxicol 93(6):1769–1770. https://doi.org/10.1007/s00204-019-02480-z Hethey C, Mielke H, Gundert-Remy U (2019b) Translational toxicology of sex specific PFNA clearance in rat and human. Arch Toxicol. https://doi.org/10.1007/s00204-019-02614-3 Kim SJ, Shin H, Lee YB, Cho HY (2018) Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model. Arch Toxicol 92(3):1113–1131. https://doi.org/10.1007/s00204-017-2116-5 Kim SJ, Choi EJ, Choi GW, Lee YB, Cho HY (2019) Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model. Arch Toxicol 93(2):311–330. https://doi.org/10.1007/s00204-018-2365-y